Clinical Trials Browser

Cardiotoxicity

NCT07515859 2026-04-13

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

Completed

31,486 enrolled

Heart Failure, Ventricular Dysfunction, Left, Cardiotoxicity

NCT06183437 2026-03-30

STOP-MED CTRCD

Phase 4 Recruiting

335 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT06778122 2026-03-27

BREATHS

Phase NA Recruiting

10 enrolled

Inflammation, Cardiotoxicity

NCT05096338 2026-03-23

PCT

Active not recruiting

200 enrolled

Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT06211413 2026-03-23

SENTINEL

Enrolling by invitation

50 enrolled

LymphoidOther hematologic neoplasm

Atrial Fibrillation, Hypertension, Leukemia, Lymphocytic, Chronic, B-Cell, Cardiotoxicity

NCT07191730 2026-03-19

ML-CardioTox

Recruiting

600 enrolled

Breast

Breast Neoplasms, Heart Failure, Neoplasms, Cardiotoxicity

NCT07442578 2026-03-18

PULSE

Phase NA Active not recruiting

20 enrolled

Cardiovascular Diseases, Cardiotoxicity

NCT06277388 2026-03-11

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.

Active not recruiting

231 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Cardiotoxicity

NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Terminated

50 enrolled

OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

NCT06844669 2026-03-03

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Phase 2 Active not recruiting

7 enrolled

Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT07405385 2026-02-12

CARE-BREAST

Phase NA Not yet recruiting

44 enrolled

Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

NCT04026737 2026-02-09

CVE-CART

Completed

44 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

NCT04361240 2026-02-09

Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study

Completed

172 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT06332131 2026-02-09

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

Enrolling by invitation

25 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cardiotoxicity

NCT06443645 2026-02-04

SCARA-B

Recruiting

50 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT04044872 2026-02-02

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

Phase EARLY_PHASE1 Terminated

3 enrolled

Breast

Unilateral Breast Neoplasms, Cardiotoxicity

NCT04928261 2026-01-22

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

Phase 4 Active not recruiting

52 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

Clinical Trials

CMR-Onko

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

STOP-MED CTRCD

BREATHS

PCT

SENTINEL

ML-CardioTox

PULSE

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

CARE-BREAST

CVE-CART

Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

SCARA-B

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy